Western Blotting Market to Rise 4.9% CAGR to Hit 2021 $US 730.7 Million by 2021

The western blotting market is projected to reach USD 730.7 million by 2021 at a CAGR of 4.9% in the next five years while North America is expected to account for the largest share of the global western blotting market




The western blotting market is undergoing a significant transformation, with the automation of blotting systems and imagers. Furthermore, it is one of the most basic technologies for the separation of proteins and is seen at almost every protein research laboratories. The growth of this market is majorly influenced by the dynamics of the protein research industries.

Complete report on western blotting market spread across 169 pages, profiling 10 companies and supported with 132 tables and 41 figures is now available at http://www.reportsnreports.com/reports/293330-western-blotting-market-by-product-instruments-manual-semi-automated-automated-consumables-kits-reagents-membrane-by-application-disease-diagnosis-agriculture-biomedical-research-end-user-analysis-global-forecast-to-2018.html .

The increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, the growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are some factors expected to drive the growth of the global western blotting market in the coming years. On the other hand, emergence of alternative technologies is expected to restrain the growth of the market. However, automation in western blotting instruments is expected to pose lucrative opportunities for the western blotting market. Furthermore, stringent regulations and requirement of high procedural efficiency for accurate results are likely to challenge the western blotting market in the coming years.

In 2016, North America is expected to account for the largest share of the global western blotting market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW).North America’s large share is attributed to the increasing prevalence of HIV and Lyme disease, U.S. –China collaborative program for biomedical research, rise in research funding & increasing production of genetically modified crops in the U.S., HIV vaccine initiative, and Growing intensity of pharmaceutical and biopharmaceutical clinical research in Canada. In the coming years, the western blotting market is expected to witness the highest growth in the Asia-Pacific region, with emphasis on India, China, and Japan. This can be attributed to factors such as presence of bio clusters in China and India, outsourcing of research activity in China, increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing pharmaceutical & biotechnology industry in Japan, growing pharmaceutical industry backed by government funding in India, and growing funding for agriculture research in India.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (expansions; new product launches; marketing and promotion; agreements, collaborations, partnerships, and joint ventures; funding; acquisitions; and product enhancement to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the adaptive security market place.

• By Company Type: Tier 1: 50%, Tier 2: 35%, Tier 3: 15%

• By Designation: Director Level: 53%, C-Level: 28%, Others: 19%

• By Region: North America: 35%, Europe: 25%, APAC: 28%, ROW: 12%

The report includes the study of key players offering western blotting such as Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.S.), Advasta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Cell Signaling Technology, Inc. (U.S.).

Request a discount on a copy of Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2021 research report at http://www.reportsnreports.com/contacts/discount.aspx?name=293330 .

The report provides a picture on western blotting instruments and consumables across different applications and regions. It aims at estimating the market size and future growth potential of this market across different segments such as product, application, end user, and regions. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Inquiry Before Buying on this Report http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=293330 .

About Us:

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: ReportsnReports
Address: 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001 Maharashtra, India.
Phone: +1-888-391-5441
Website: http://www.reportsnreports.com

Release ID: 145046